Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab
Xuefeng Wang(Jiangsu University), Christine H. Chung(Moffitt Cancer Center), José A. Guevara-Patiño(Moffitt Cancer Center), Marcelo Bonomi, Nabil F. Saba(Emory University), Tingyi Li(Moffitt Cancer Center), Robbert J.C. Slebos(University of Iowa)
Cited by 10
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
|Cell Metabolism|2012|1.1k